Get the Stockscreener App
82.90
0.44%
0.36
After Hours:
83.46
0.56
+0.68%
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Stock Split
Dividend History
Medtronic Plc stock is traded at $82.90, with a volume of 8.01M.
It is up +0.44% in the last 24 hours and down -11.13% over the past month.
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.
See More
Previous Close:
$82.54
Open:
$83.16
24h Volume:
8.01M
Relative Volume:
1.09
Market Cap:
$105.84B
Revenue:
$33.20B
Net Income/Loss:
$4.26B
P/E Ratio:
25.20
EPS:
3.29
Net Cash Flow:
$5.47B
1W Performance:
+0.02%
1M Performance:
-11.13%
6M Performance:
-7.23%
1Y Performance:
+0.89%
1-Day Range:
$81.18
$83.44
1-Week Range:
$79.55
$85.50
52-Week Range:
$75.96
$96.25
Medtronic Plc Stock (MDT) Company Profile
Name
Medtronic Plc
Sector
Industry
Phone
01135314381700
Address
BUILDING TWO PARKMORE BUSINESS PARK WEST, GALWAY
Compare MDT with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
MDT
Medtronic Plc
|
82.90 | 105.84B | 33.20B | 4.26B | 5.47B | 3.29 |
|
ABT
Abbott Laboratories
|
126.88 | 220.05B | 41.95B | 13.40B | 6.35B | 7.65 |
|
BSX
Boston Scientific Corp
|
93.67 | 138.54B | 16.75B | 1.85B | 2.37B | 1.25 |
|
SYK
Stryker Corp
|
350.28 | 132.98B | 22.60B | 2.99B | 3.49B | 7.76 |
|
EW
Edwards Lifesciences Corp
|
69.40 | 39.98B | 5.72B | 4.17B | 259.90M | 6.97 |
Medtronic Plc Stock (MDT) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Upgrade | Citigroup | Neutral → Buy |
| Oct-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Aug-21-24 | Reiterated | Oppenheimer | Perform |
| Aug-15-24 | Upgrade | UBS | Sell → Neutral |
| Aug-14-24 | Downgrade | Stifel | Buy → Hold |
| May-30-24 | Initiated | Goldman | Sell |
| Jul-19-23 | Initiated | Robert W. Baird | Neutral |
| Jun-30-23 | Initiated | CL King | Buy |
| May-30-23 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Apr-24-23 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Mar-29-23 | Downgrade | UBS | Buy → Sell |
| Jan-09-23 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| Nov-23-22 | Downgrade | Citigroup | Buy → Neutral |
| Nov-23-22 | Downgrade | Oppenheimer | Outperform → Perform |
| Nov-16-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Equal Weight |
| Oct-13-22 | Initiated | Mizuho | Buy |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Aug-24-22 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Jul-06-22 | Initiated | Wolfe Research | Underperform |
| Jun-01-22 | Downgrade | Atlantic Equities | Overweight → Neutral |
| May-27-22 | Downgrade | Needham | Buy → Hold |
| Apr-13-22 | Downgrade | Truist | Buy → Hold |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-10-22 | Downgrade | BTIG Research | Buy → Neutral |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-17-21 | Downgrade | JP Morgan | Overweight → Neutral |
| Dec-16-21 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Outperform |
| Jun-10-21 | Resumed | Cowen | Outperform |
| May-25-21 | Initiated | Barclays | Equal Weight |
| Apr-15-21 | Initiated | Atlantic Equities | Overweight |
| Dec-15-20 | Upgrade | Goldman | Sell → Neutral |
| Dec-15-20 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Oct-08-20 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Oct-08-20 | Upgrade | Stifel | Hold → Buy |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| May-14-20 | Downgrade | DZ Bank | Buy → Hold |
| Mar-30-20 | Downgrade | Needham | Strong Buy → Buy |
| Mar-25-20 | Upgrade | DZ Bank | Hold → Buy |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Sell |
| Jan-08-20 | Initiated | SunTrust | Buy |
| Jan-02-20 | Upgrade | Guggenheim | Neutral → Buy |
| Jun-05-19 | Upgrade | Wells Fargo | Market Perform → Outperform |
| Feb-04-19 | Reiterated | Needham | Strong Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Downgrade | Citigroup | Buy → Neutral |
| Dec-19-18 | Upgrade | JP Morgan | Neutral → Overweight |
| Nov-28-18 | Initiated | UBS | Buy |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-27-18 | Reiterated | Argus | Buy |
View All
Medtronic Plc Stock (MDT) Latest News
Truist Trims Price Target on Medtronic to $90 From $93, Keeps Hold Rating - MarketScreener
Baird Adjusts Price Target on Medtronic to $94 From $91, Maintains Neutral Rating - MarketScreener
Intramedullary Nail Market size to worth USD 1,537 Million by 2032, says Coherent Market Insights - GlobeNewswire Inc.
Medtronic Becomes Oversold - Nasdaq
Medtronic's MiniMed 780G Leads in Time in Target Range for Type 1 Diabetes - Medical Device and Diagnostic industry
Citigroup Adjusts Medtronic Price Target to $103 From $107, Maintains Buy Rating - MarketScreener
Looking Into Medtronic's Recent Short Interest - Benzinga
Medtronic PLC (MDT) Shares Gap Down to $84.31 on Apr 4 - GuruFocus
Piper Sandler maintains Medtronic stock neutral with $90 target By Investing.com - Investing.com UK
Medtronic (MDT) Stock Moves -1.09%: What You Should Know - Nasdaq
May 23rd Options Now Available For Medtronic (MDT) - Nasdaq
Boston Scientific’s Farapulse matches Medtronic cryoablation in trial - MedTech Dive
Medtronic (MDT) Advances But Underperforms Market: Key Facts - Yahoo Finance
Former Medtronic CEO Criticizes RFK Jr.'s HHS Leadership - Medical Device and Diagnostic industry
Medtronic, Recor commence hostilities over RDN patents - BioWorld MedTech
3 takeaways from ACC 2025 - MedTech Dive
Evercore ISI Adjusts Medtronic Price Target to $105 From $104, Maintains Outperform Rating - MarketScreener
Boston Scientific’s Farapulse Triumphs Over Medtronic’s Artic Front in Atrial Fibrillation Trial - Medical Device and Diagnostic industry
The Zacks Analyst Blog Highlights Mastercard, Medtronic, HCA Healthcare and United Homes - Nasdaq
Medtronic plc (NYSE:MDT) Stake Boosted by Geode Capital Management LLC - MarketBeat
Medtronic Breaks Out Strong TAVR Data at ACC - Medical Device and Diagnostic industry
Top Stock Reports for Mastercard, Medtronic & HCA Healthcare - MSN
Medtronic (NYSE:MDT) TAVR System Shows Strong Five-Year Performance Despite 3% Price Dip - Yahoo
Stifel maintains Hold on Medtronic stock, sets $87 target By Investing.com - Investing.com UK
Medtronic Aortic Valve Replacement Device Shows Improvements Over Surgery in Heart Patients - MarketScreener
Medtronic plc (NYSE:MDT) Shares Sold by Meeder Asset Management Inc. - MarketBeat
Medtronic plc (MDT): Among the Best Dividend Aristocrat Stocks with Over 3% Yield - Insider Monkey
Medtronic Evolut™ TAVR system shows durable clinical outcomes and outstanding valve performance at five years in low-risk aortic stenosis patients - Medtronic
5-Year Clinical Data: Medtronic TAVR Outperforms Traditional Surgery with Better Heart Outcomes - Stock Titan
Prediction: Buying Medtronic Today Will Set You Up for Life - The Motley Fool
Prestige Wealth Management Group LLC Has $344,000 Stock Position in Medtronic plc (NYSE:MDT) - MarketBeat
Fed. Circ. Revives Recor's PTAB Challenge To Medtronic IP - Law360
Medtronic (MDT) Increases Despite Market Slip: Here's What You Need to Know - Yahoo Finance
Medtronic shares trade in green after seven straight days of losses - Seeking Alpha
Otsuka Gets Another Shot Challenging Medtronic Patent's Validity - Bloomberg Law News
Medtronic: A Great Business, But With Low Growth - Seeking Alpha
Is Medtronic plc (MDT) the Best Consistent Dividend Stock to Buy? - Insider Monkey
Ex-Dividend Reminder: Dick's Sporting Goods, Medtronic and DENTSPLY SIRONA - Nasdaq
Medtronic rolls out Affera PFA system in Sweden with more Nordic countries to follow - Mass Device
The Zacks Analyst Blog Boston Scientific, Abbott and Medtronic - Yahoo Finance
Recent U.S. Food and Drug Administration (FDA) approvals - Today's Medical Developments
Investors Heavily Search Medtronic PLC (MDT): Here is What You Need to Know - Yahoo Finance
Looking At Medtronic's Recent Unusual Options Activity - Benzinga
Catheters Market Is Booming Worldwide 2025-2032 | Medtronic, ConvaTec, Inc., Smith Medical, Hollister Incorporated - openPR
Medtronic reports first real-world data on smart insulin pen system - Mass Device
Medtronic’s Evolut trial outcome could shift US TAVR market - Yahoo Finance
Medtronic (MDT) Up 5.6% Since Last Earnings Report: Can It Continue? - Yahoo Finance
An Insider At Medtronic Lowered Their Holding Recently - simplywall.st
Safety Needles Market Detailed In New Research Report 2025 | - openPR
Medtronic: Strength In Cardiac Ablation Solutions, Upgrade To Buy - Seeking Alpha
Medtronic, Abbott Block Boston Scientific Heart Valve IP - Law360
Medtronic Plc Stock (MDT) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.54%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):